Baillie Gifford & Co

Q2 2022 13F Holdings Report, Stock Holdings

Signature - Title
Grant Meikle - Compliance Manager
Location
Edinburgh
Holdings as of
June 30, 2022
Value $
$96.2B
Num holdings
480
Date filed
8/8/2022, 07:46 AM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included MRNA, TSLA, AMZN, ILMN, and MELI.
Previous filing
Q1 2022 - May 5, 2022
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q2 compared to 2022 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Grant Meikle Compliance Manager Edinburgh, United Kingdom 8/8/2022

Other Included Managers (4):

Num Name Location File Number
1 Baillie Gifford & Co Ltd Edinburgh, United Kingdom 028-04841
2 Baillie Gifford Overseas Ltd Edinburgh, United Kingdom 028-04395
3 Baillie Gifford Investment Management (Europe) Ltd Dublin, Ireland 028-19482
4 Baillie Gifford International LLC Edinburgh, United Kingdom 028-20241